1. Home
  2. EHTH vs ANIX Comparison

EHTH vs ANIX Comparison

Compare EHTH & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$1.29

Market Cap

104.0M

Sector

Finance

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.58

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
ANIX
Founded
1997
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
104.0M
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
EHTH
ANIX
Price
$1.29
$2.58
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$3.33
$8.67
AVG Volume (30 Days)
826.6K
92.7K
Earning Date
05-06-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
12.82
EPS
N/A
N/A
Revenue
$251,395,000.00
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$2.33
52 Week High
$7.09
$5.46

Technical Indicators

Market Signals
Indicator
EHTH
ANIX
Relative Strength Index (RSI) 33.45 41.76
Support Level $1.20 N/A
Resistance Level $1.72 $3.10
Average True Range (ATR) 0.10 0.19
MACD 0.02 -0.01
Stochastic Oscillator 12.77 32.20

Price Performance

Historical Comparison
EHTH
ANIX

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: